Houston Center

Re:Cognition Health Houston opened its doors in November 2022. Currently, the Center is specializing in phase 2 and 3 pharmaceutical trials focused on finding a disease-modifying medication to treat those suffering from Mild Cognitive Impairment and Alzheimer’s Disease. Our research team is made up of a variety of professionals committed to the highest quality care and patient satisfaction.